Skip to content

Shuji Ogino

OLYMPUS DIGITAL CAMERA

Shuji Ogino, MD, PhD, is Professor in the Department of Epidemiology, Harvard T.H. Chan School of Public Health; and Professor of Pathology at Harvard Medical School, Brigham and Women’s Hospital, and Dana-Farber Cancer Institute.  He is the only Harvard University faculty member who holds appointments in both Epidemiology and Pathology.  Dr. Ogino received MD and PhD degrees from University of Tokyo, and MS degree from Harvard T.H. Chan School of Public Health.  As a board-certified molecular genetic pathologist, he has been developing clinical cancer genomic testing.  Dr. Ogino is making a new bridge between pathology and epidemiology in education and research.

Dr. Ogino has been spearheading to lead integrative science of “Molecular Pathological Epidemiology (MPE)” (S Ogino et al. J Natl Cancer Inst 2010; Nat Rev Clin Oncol 2011; Int J Epidemiol 2012; Am J Epidemiol 2012; etc.) with its paradigm-shifting effects on population health sciences.  Dr. Ogino founded The International MPE Meeting Series in 2013, and its 2nd meeting concluded as a resounding success in December, 2014.  He will co-chair The Third International MPE Meeting in Boston in spring 2016.  With his unique viewpoints, Dr. Ogino has created novel paradigms, frameworks and initiatives, including “GWAS-MPE Approach” (Gut 2011), “Unique Tumor Principle” (Expert Rev Mol Diagn 2012), “Colorectal Continuum Model” (Gut 2012), “STROBE-MPE Initiative” (Am J Epidemiol 2012), “Unique Disease Principle” (Mod Pathol 2013), “Etiologic Field Effect Model” (Mod Pathol 2015), and “Lifecourse – MPE Model” (Am J Prev Med 2015).  Recent highlights of his MPE research include two New England Journal of Medicine (NEJM) papers (X Liao et al. 2012; R Nishihara et al. 2013) and Gut 2015 paper, which created a new frontier of science, “immuno-MPE”, an integration of cancer immunology, molecular pathology and epidemiology.

Dr. Ogino received Ramzi Cotran Young Investigator Award (2011) from United States and Canadian Academy of Pathology (USCAP), and Executive Officer’s Award (2004) and Meritorious Service Award (2012) from Association for Molecular Pathology (AMP); and has been an elected member of an honorary society, American Society for Clinical Investigation (ASCI).  In 2014, Dr. Ogino was recognized among “The Best of AACR Journals” and “The Most Influential Scientific Minds: 2014” by Thomson Reuters.